dsm-firmenich completes the divestiture of its Jiangshan vitamin C plant in China

Published: 8-Mar-2024
Finance

Financial details of the transaction were not disclosed

dsm-firmenich has announced the successful sale and transfer of its 100% equity interest in DSM Jiangshan Pharmaceutical Co., Ltd to Jingjiang Cosfocus Health Technology Co., Ltd.

dsm-firmenich announced on 28 June 2023 it was exploring a range of options for the Jiangshan vitamin C plant in Jinjiang, China.
 

  • Companies:
  • dsm-firmenich
See more

You may also like

Training & Education

dsm-firmenich awards Nutrition Research Grants totalling €250,000 to APAC-based gut health researchers

Read more
The nutrition-focused company will award up to €50,000 to each recipient to advance research on pre-, pro- and postbiotics, as well as human milk oligosaccharides (HMOs) on gut health and overall wellness

Trending Articles

  1. dsm-firmenich awards Nutrition Research Grants totalling €250,000 to APAC-based gut health researchers The nutrition-focused company will award up to €50,000 to each recipient to advance research on pre-, pro- and postbiotics, as well as human milk oligosaccharides (HMOs) on gut health and overall wellness
  2. Dr. Anju Majeed welcomes Maldivian president at the India-Maldives Business Forum Forum aims to strengthen bilateral ties and explore investment opportunities
  3. CV Sciences acquires premium cannabinoid producer and distributor, Extract Labs Extract Labs' range of nutraceuticals suitable for both B2B and B2C customers will bolster CV Science's product range, which include plant-based ingredients and functional foods
  4. Green Bioactives receives £224,000 to develop its plant metabolite biomanufacturing platform The funding from Innovate UK will allow the company to accelerate the development of its botanical metabolite biomanufacturing platform
  5. Happy Plant Protein secures €1.8m to develop and license its plant-based protein ingredients The manufacturing process developed by Happy Plant Protein can reduce plant-based protein production costs by up to 90%, while also creating functional food products with a 70–80% protein content

Upcoming event

Vitafoods India

5–7 February 2025 | Exhibition | Mumbai See all

You may also like

Training & Education

dsm-firmenich awards Nutrition Research Grants totalling €250,000 to APAC-based gut health researchers

The nutrition-focused company will award up to €50,000 to each recipient to advance research on pre-, pro- and postbiotics, as well as human milk oligosaccharides (HMOs) on gut health and overall wellness
Finance

KD Pharma Group completes acquisition of dsm-firmenich's Marine Lipids business

The transaction positions KD Pharma Group as the largest omega-3 manufacturer in the world
Finance

KD Pharma secures dsm-firmenich's MEG-3 fish oil business in strategic acquisition

KD Pharma will gain all of the MEG-3's assets, including two production facilities and around 200 employees
Finance

dsm-firmenich announces sale of yeast extract business to Lesaffre

dsm-firmenich, innovators in nutrition, health and beauty, has announced an agreement to sell its yeast extract business (Yeast Extracts) to Lesaffre, a key global player in fermentation and micro-organisms
Finance

dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans

The company has repurchased 500,000 shares for a total consideration of €51.6m
Ingredients

dsm-firmenich announces repurchase of 1.5m shares to cover share plans

The repurchasing of shares equates to around €156m
Finance

dsm-firmenich to separate out Animal Nutrition & Health business from the Group

The company will be placing a full focus on nutrition, health and beauty
Subscribe now